Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEST-MS
2013-002433-38Phase 4Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Sep 2015
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of natalizumab and fingolimod in multiple sclerosis (MS) (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Started Sep 2015; status: completed.
02
Drugs
natalizumabfingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2013-002433-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002433-38.